Quote | Tarsus Pharmaceuticals Inc. (NASDAQ:TARS)
Last: | $28.93 |
---|---|
Change Percent: | 0.0% |
Open: | $27.56 |
Close: | $28.93 |
High: | $29.14 |
Low: | $26.8 |
Volume: | 406,625 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Tarsus Pharmaceuticals Inc. (NASDAQ:TARS)
2024-06-25 14:07:48 ET More on iShares Russell 2000 ETF: IWM: Small Caps Look Unattractive With Deteriorating Earnings Outlook IWM: Favor Small Caps Over The Technology Sector IWM: Not The Economy For Underdogs (Rating Downgrade) Gap between growth and small-...
2024-06-03 08:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Tarsus Pharmaceuticals Inc. (NASDAQ:TARS)
Subject | By | Source | When |
---|---|---|---|
AviseAnalytics: $TARS ALL EYES ON TARSUS PHARMACEUTICALS! https://www.aviseanalytics.com/all-eyes-on | AviseAnalytics | investorshangout | 07/02/2021 12:13:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Tarsus Pharmaceuticals Inc. Company Name:
TARS Stock Symbol:
NASDAQ Market:
Tarsus Pharmaceuticals Inc. Website:
2024-06-03 08:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that management will participate in t...
2024-05-13 07:00:04 ET Oren Livnat from H.C. Wainwright issued a price target of $61.00 for TARS on 2024-05-13 06:01:00. The adjusted price target was set to $61.00. At the time of the announcement, TARS was trading at $37. TARS currently trades -5.98% versus its 52 week...